Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Plasma cell 1Gastrointestinal 1Breast 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1Esophageal Neoplasms 1COVID-19 1Breast Neoplasms 1

Interventions

Cyclophosphamide 909Carboplatin 786Paclitaxel 741pembrolizumab 741Bevacizumab 715Cisplatin 707Gemcitabine 621Docetaxel 583Rituximab 558Radiotherapy 546Dexamethasone 510Nivolumab 488Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 357Pemetrexed 336Oxaliplatin 335Cytarabine 334Lenalidomide 327Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 315Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 275

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Patient Reported Outcome Measures × Clear all
NCT05831787 2026-05-18

COSMIC

ASH Research Collaborative

Completed
201 enrolled 15 charts
Plasma cell

COVID-19, Multiple Myeloma, Neoplasms, Plasma Cell

NCT03482791 2026-04-02

Proton Beam Therapy in the Treatment of Esophageal Cancer

Washington University School of Medicine

Phase NA Active not recruiting
22 enrolled 29 charts
Gastrointestinal

Esophageal Neoplasms

NCT04272801 2025-10-22

POWER

University of Virginia

Phase 2 Active not recruiting
84 enrolled 9 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡